NO994612L - Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus - Google Patents

Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus

Info

Publication number
NO994612L
NO994612L NO994612A NO994612A NO994612L NO 994612 L NO994612 L NO 994612L NO 994612 A NO994612 A NO 994612A NO 994612 A NO994612 A NO 994612A NO 994612 L NO994612 L NO 994612L
Authority
NO
Norway
Prior art keywords
insulin
treatment
diabetes mellitus
dependent diabetes
retinoid
Prior art date
Application number
NO994612A
Other languages
English (en)
Norwegian (no)
Other versions
NO994612D0 (no
Inventor
Magnus Pfahl
Waldemar Lernhardt
Andrea Fanjol
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of NO994612D0 publication Critical patent/NO994612D0/no
Publication of NO994612L publication Critical patent/NO994612L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Physical Vapour Deposition (AREA)
NO994612A 1997-03-24 1999-09-22 Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus NO994612L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3560497P 1997-03-24 1997-03-24
PCT/US1998/005591 WO1998042340A1 (en) 1997-03-24 1998-03-24 Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
NO994612D0 NO994612D0 (no) 1999-09-22
NO994612L true NO994612L (no) 1999-11-24

Family

ID=21883695

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994612A NO994612L (no) 1997-03-24 1999-09-22 Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus

Country Status (11)

Country Link
EP (1) EP1019049A1 (pt)
JP (1) JP2001521551A (pt)
KR (1) KR20010005678A (pt)
CN (1) CN1256630A (pt)
AU (1) AU6576398A (pt)
BR (1) BR9808054A (pt)
CA (1) CA2284192A1 (pt)
IL (1) IL132032A0 (pt)
NO (1) NO994612L (pt)
NZ (1) NZ337927A (pt)
WO (1) WO1998042340A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR023700A1 (es) * 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
KR100643833B1 (ko) * 1998-11-12 2006-11-10 스미스클라인비이참피이엘시이 인슐린 감작제 및 다른 항당뇨병 약제의 개선된 방출을위한 제약 조성물
WO2002100396A1 (en) * 2001-06-07 2002-12-19 Wyeth COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT
CN1921843A (zh) * 2004-01-23 2007-02-28 独立行政法人科学技术振兴机构 含视黄酸的糖尿病治疗药
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
CA2937107C (en) 2014-01-17 2020-12-22 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04504847A (ja) * 1989-03-08 1992-08-27 ザ　ユニバーシティ　オヴ　バージニア　パテント　ファウンデーション インスリン抵抗性糖尿病のための食事用補添物
FR2695317B1 (fr) * 1992-09-07 1995-03-10 Monal Lab Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant.
AU676227B2 (en) * 1993-01-22 1997-03-06 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Therapeutic agent for NIDDM
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5444086A (en) * 1994-03-31 1995-08-22 American Home Products Corporation Naphthalenylmethyl thiophenones as antihyperglycemic agents

Also Published As

Publication number Publication date
WO1998042340A1 (en) 1998-10-01
JP2001521551A (ja) 2001-11-06
CA2284192A1 (en) 1998-10-01
NZ337927A (en) 2000-11-24
KR20010005678A (ko) 2001-01-15
BR9808054A (pt) 2000-11-07
CN1256630A (zh) 2000-06-14
IL132032A0 (en) 2001-03-19
NO994612D0 (no) 1999-09-22
AU6576398A (en) 1998-10-20
EP1019049A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
Kuypers Skin problems in chronic kidney disease
Salah Clinical and dermoscopic spectrum of discoid lupus erythematosus: novel observations from lips and oral mucosa
Ferrari et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent
Fouque et al. Eleven reasons to control the protein intake of patients with chronic kidney disease
Rukmini et al. Antibacterial Efficacy of Tender Coconut Water (Cocos nucifera L) on Streptococcus mutans: An: In-Vitro: Study
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
NO20053537L (no) Preparater og fremgangsmater for forebyggelse og kontroll av insulinindusert hypoglycemi.
NO20054343L (no) Behandling av immunologiske lidelser ved anvendelse av agonister av interleukin-21/interleukin-21 reseptor
HUP0004170A2 (hu) Eljárás és anyagok nyálkaszövetek gyulladásának kezelésére és megelőzésére
WO1998048785A3 (en) Allelic polygene diagnosis of reward deficiency syndrome and treatment
NO972475L (no) Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav
Gkogkolou et al. Skin disorders in diabetes mellitus
NO994612L (no) Retinoid-relaterte molekyler for behandling av ikke-insulinavhengig diabetes mellitus
Heerfordt et al. Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial
Girija et al. Aristolochia bracteolata enhances wound healing in vitro through anti-inflammatory and proliferative effect on human dermal fibroblasts and keratinocytes
Pandya et al. Taurine can enhance the protective actions of metformin against diabetes-induced alterations adversely affecting renal function
Wali et al. Attenuation of oxidative damage-associated hepatotoxicity by piperine in CCl4-induced liver fibrosis
Bowes et al. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest
AR004326A1 (es) Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista.
Kauser et al. Bradykinin-induced, Nω-nitro-l-arginine-insensitive endothelium-dependent relaxation of porcine coronary arteries is not mediated by bioassayable relaxing substances
NO934798D0 (no) Anvendelse av 2-(2-nitro-4-trifluormetylbenzoyl)-1,3-cykloheksand ion ved behandling av tyrosinemia og farmasoeytiske preparater
MX160743A (es) Composicion para tratar el cabello
Prins Models for treatment efficacy studies of adult stutterers.
Nam et al. Evaluation of delphinidin as a storage medium for avulsed teeth
NO961589L (no) Farmasöytiske blandinger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application